Interestingly, there is evidence for an inverse correlation between AR and EGFR expression in PCa disease progression [40], and a shift from AR towards EGFR expression could contribute to the resistance against AR targeting therapy in advanced PCa. This evidence concerns the gene EGFR and posterior cortical atrophy.